Evolva and Valent BioSciences Corp. (VBC) announced in March they have signed an exclusive agreement to co-develop and market a class of high-value active ingredients for use as next-generation agricultural bioactives.
The companies said the ingredients are not being identified for competitive reasons. Evolva will develop the yeast strains to make the desired ingredients, and VBC will commercialize them. The companies will work together on scale-up and manufacturing, with the first products expected be marketed in four to five years.
Use of bioactives is growing because they help growers improve crop yields without any negative impact on human health or the environment. They are used in both organic and conventional agriculture and horticulture and play an important part in sustainable farming.
Organizations in this story
Evolva San Francisco 101 Larkspur Landing Cir Larkspur, CA 94939
- Montana lawmakers preserve private-road rights
- Nevada cautions horse owners after reports of EHV-4, strangles
- American Farm Bureau Federation outlines concerns at USDA forum
- Kansas looks for beef trade mission participants
- Project to introduce drought-resistant maize continues in Africa
- American Soybean Association outlines its concerns on Farm Bill
- Commodity Classic set to kick off in San Antonio
- Second-graders enjoy a day of 'Ag Venture'
- Florida offers potentially life-saving app
- Connecticut hopes third time's a charm for conservationists